Literature DB >> 31328526

Size-Dependent Interaction of Amyloid β Oligomers with Brain Total Lipid Extract Bilayer-Fibrillation Versus Membrane Destruction.

Dusan Mrdenovic1,2, Marta Majewska1, Izabela S Pieta1, Piotr Bernatowicz1, Robert Nowakowski1, Wlodzimierz Kutner1,3, Jacek Lipkowski2, Piotr Pieta1.   

Abstract

Amyloid β, Aβ(1-42), is a component of senile plaques present in the brain of Alzheimer's disease patients and one of the main suspects responsible for pathological consequences of the disease. Herein, we directly visualize the Aβ activity toward a brain-like model membrane and demonstrate that this activity strongly depends on the Aβ oligomer size. PeakForce quantitative nanomechanical mapping mode of atomic force microscopy imaging revealed that the interaction of large-size (LS) Aβ oligomers, corresponding to high-molecular-weight Aβ oligomers, with the brain total lipid extract (BTLE) membrane resulted in accelerated Aβ fibrillogenesis on the membrane surface. Importantly, the fibrillogenesis did not affect integrity of the membrane. In contrast, small-size (SS) Aβ oligomers, corresponding to low-molecular-weight Aβ oligomers, created pores and then disintegrated the BTLE membrane. Both forms of the Aβ oligomers changed nanomechanical properties of the membrane by decreasing its Young's modulus by ∼45%. Our results demonstrated that both forms of Aβ oligomers induce the neurotoxic effect on the brain cells but their action toward the membrane differs significantly.

Entities:  

Year:  2019        PMID: 31328526     DOI: 10.1021/acs.langmuir.9b01645

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  7 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  Challenges in Experimental Methods.

Authors:  Marlena E Gąsior-Głogowska; Natalia Szulc; Monika Szefczyk
Journal:  Methods Mol Biol       Date:  2022

3.  Lipid membranes induce structural conversion from amyloid oligomers to fibrils.

Authors:  Lei Gu; Zhefeng Guo
Journal:  Biochem Biophys Res Commun       Date:  2021-04-14       Impact factor: 3.322

4.  Inhibition of Amyloid β-Induced Lipid Membrane Permeation and Amyloid β Aggregation by K162.

Authors:  Dusan Mrdenovic; Piotr Zarzycki; Marta Majewska; Izabela S Pieta; Robert Nowakowski; Wlodzimierz Kutner; Jacek Lipkowski; Piotr Pieta
Journal:  ACS Chem Neurosci       Date:  2021-01-22       Impact factor: 4.418

5.  Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.

Authors:  Unekwu M Yakubu; Celso S G Catumbela; Rodrigo Morales; Kevin A Morano
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

6.  A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease.

Authors:  Ping He; Philip Schulz; Michael R Sierks
Journal:  J Biol Chem       Date:  2021-01-09       Impact factor: 5.157

7.  Alzheimer's disease-related amyloid β peptide causes structural disordering of lipids and changes the electric properties of a floating bilayer lipid membrane.

Authors:  Dusan Mrdenovic; Zhangfei Su; Wlodzimierz Kutner; Jacek Lipkowski; Piotr Pieta
Journal:  Nanoscale Adv       Date:  2020-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.